Truncus arteriosus is a rare congenital heart disease/defect. If the baby has truncus arteriosus, it means that one large blood vessel leads out of the heart instead of two separate vessels. Moreover, in this condition, usually, there is a hole known as a ventricular septal defect present between the two lower chambers of the heart. As a result of truncus arteriosus, oxygen-poor blood that should go to the lungs and oxygen-rich blood that should go to the rest of the body are mixed together which leads to severe circulatory problems. However, if untreated, truncus arteriosus can be fatal.
View Reports Sample @ https://www.marketresearchfuture.com/sample_request/5260
The global truncus arteriosus market is expecting a sound growth in coming future owing to the increasing demand for various cardiovascular devices, increasing prevalence of cardiovascular diseases, and favorable reimbursement policies. In some cases, maternal diabetes may lead to truncus arteriosus. However, mostly all diabetic patients suffer from some or the other cardiovascular disease. According to the findings from the WHO in 2014, approximately 422 million people reported suffering from diabetes. Due to the increasing diabetic population across the globe, there is a significant increase in the number of people suffering from cardiovascular diseases. According to the World Health Organization (WHO), in 2015, over 17.7 million people died from cardiovascular diseases, representing 31% of all global deaths of which 82% were in the low- and middle-income countries. Additionally, according to the Centers for Disease Control and Prevention (2015), over 630,000 Americans die from heart disease each year, which accounts for 1 in every 4 death.
Additionally, increasing geriatric population and increasing healthcare expenditure have fuelled the growth of this market. On the other hand, higher cost of the treatments may slow the growth of the market during the forecast period.
The Truncus Arteriosus Market is expected to grow at a CAGR of 7.8% during the forecast period 2017-2023.
- Cardiovascular Products Manufacturers
- Cardiovascular Products Providers
- Medical Research Laboratories
- Research and Development (R&D) Companies
- Market Research and Consulting Service Providers
- Potential Investors
Key players in the global truncus arteriosus market:
Some of the major players in this market are Boston Scientific Corporation (U.S.), Coloplast (Denmark), Dispocard GmbH (Germany), St. Jude Medical (U.S.), Abbott Laboratories (U.S.), Johnson & Johnson (U.S.), Teleflex Incorporated (U.S.)., Smiths Medical (U.S.), Edwards Life Sciences Corporation (U.S.), Medtronic Inc (U.S.), Rochester Medical Corporation (U.S), Maquet Medical India Private Limited (India), Terumo Medical Corporation (Japan), AstraZeneca plc., Pfizer Inc., Novartis AG, Merck & Co., Inc., Bristol-Myers Squibb Company, Bayer AG, Sanofi, Boehringer Ingelheim GmbH, F. Hoffmann-La Roche Ltd, Gilead Sciences, Inc., Astellas Pharma, Inc., Eli Lilly and Company, Otsuka Holdings Co., Ltd., Takeda Pharmaceutical Company Limited.
The global truncus arteriosus market has been segmented on the basis of types, diagnosis, treatment, and end user.
On the basis of the types, the global truncus arteriosus market is segmented into type I, type II, type III.
Based on the diagnosis, it is segmented into echocardiogram and X-ray while on the basis of treatment the market is segmented into medication, surgery, cardiac catheterization, and others.
The medication segment can be further segmented into diuretics, ionotropic agents.
On the basis of the end users, the market is segmented into hospitals & clinics, cardiac care centers, ambulatory centers & home care, academic institutes, and others.
Table Of Content
1. Report Prologue
2. Market Introduction
2.2 Scope Of The Study
2.2.1 Research Objective
3. Research Methodology
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
4. Market Dynamics
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
5. Market Factor Analysis
5.1 Porters Five Forces Analysis
5.1.1 Bargaining Power Of Suppliers
5.1.2 Bargaining Power Of Buyers
5.1.3 Threat Of New Entrants
5.1.4 Threat Of Substitutes
5.1.5 Intensity Of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
Report with Discount Available @ https://www.marketresearchfuture.com/check-discount/5260
Asia Pacific is the fastest growing truncus arteriosus market. Increasing need for better devices, rapidly improving technology, and the presence of huge patient pool is driving the growth of the market in this region.
The Middle East & Africa holds the least share of the market owing to the presence of poor and slow developing countries, especially, in the African region. The major driving factors for the growth of the Middle East & African truncus arteriosus market are increasing a number of diabetic and cardiovascular patients.
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar